Hiroyuki Watanabe

Publication Activity (10 Years)

Years Active: 2015-2024
Publications (10 Years): 38

Top Topics

Computed Tomography

Single Molecule

Top Venues

Journal of labelled compounds & radiopharmaceuticals

ACS chemical neuroscience

Chemical communications (Cambridge, England)

Molecular pharmaceutics

This page only lists publications with an associated author ORCID identifier.

Publications

Ryotaro Onoue, Hiroyuki Watanabe, Masahiro Ono
Development of Novel Bimodal Agents Based on Near-Infrared BODIPY-Conjugated Hoechst Derivatives for Combined Use in Auger Electron and Photodynamic Cancer Therapy. ACS pharmacology & translational science 7 (5) (2024)
Kotaro Nagashima, Hiroyuki Watanabe, Takahiro Akasaka, Masahiro Ono
Development of Triphenylmethane Dyes for In Vivo Fluorescence Imaging of Aβ Oligomers. ACS chemical neuroscience 15 (11) (2024)
Kotaro Nagashima, Hiroyuki Watanabe, Takahiro Akasaka, Masahiro Ono
Development of Triphenylmethane Dyes for In Vivo Fluorescence Imaging of Aβ Oligomers. ACS chemical neuroscience (2024)
Hiroki Jinda, Kazuma Nakashima, Hiroyuki Watanabe, Masahiro Ono
Synthesis and Evaluation of a Cathepsin B-Recognizing Trifunctional Chelating Agent to Improve Tumor Retention of Radioimmunoconjugates. Journal of labelled compounds & radiopharmaceuticals 67 (8) (2024)
Hiroki Jinda, Kazuma Nakashima, Hiroyuki Watanabe, Masahiro Ono
Synthesis and Evaluation of a Cathepsin B-Recognizing Trifunctional Chelating Agent to Improve Tumor Retention of Radioimmunoconjugates. Journal of labelled compounds & radiopharmaceuticals 67 (8) (2024)
Hiroki Jinda, Kazuma Nakashima, Hiroyuki Watanabe, Masahiro Ono
Synthesis and Evaluation of a Cathepsin B-Recognizing Trifunctional Chelating Agent to Improve Tumor Retention of Radioimmunoconjugates. Journal of labelled compounds & radiopharmaceuticals (2024)
Hiroki Jinda, Kazuma Nakashima, Hiroyuki Watanabe, Masahiro Ono
Synthesis and Evaluation of a Cathepsin B-Recognizing Trifunctional Chelating Agent to Improve Tumor Retention of Radioimmunoconjugates. Journal of labelled compounds & radiopharmaceuticals 67 (8) (2024)
Nobuki Kazuta, Kazuma Nakashima, Hiroyuki Watanabe, Masahiro Ono
Effect of Linker Entities on Pharmacokinetics of 111 In-Labeled Prostate-Specific Membrane Antigen-Targeting Ligands with an Albumin Binder. ACS pharmacology & translational science 7 (8) (2024)
Nobuki Kazuta, Kazuma Nakashima, Hiroyuki Watanabe, Masahiro Ono
Effect of Linker Entities on Pharmacokinetics of 111 In-Labeled Prostate-Specific Membrane Antigen-Targeting Ligands with an Albumin Binder. ACS pharmacology & translational science 7 (8) (2024)
Kotaro Nagashima, Hiroyuki Watanabe, Takahiro Akasaka, Masahiro Ono
Development of Triphenylmethane Dyes for In Vivo Fluorescence Imaging of Aβ Oligomers. ACS chemical neuroscience 15 (11) (2024)
Hiroki Jinda, Hiroyuki Watanabe, Kazuma Nakashima, Masahiro Ono
Application of Microfluidic Devices for Automated Two-Step Radiolabeling of Antibodies. Journal of labelled compounds & radiopharmaceuticals (2024)
Kotaro Nagashima, Hiroyuki Watanabe, Takahiro Akasaka, Masahiro Ono
Development of Triphenylmethane Dyes for In Vivo Fluorescence Imaging of Aβ Oligomers. ACS chemical neuroscience 15 (11) (2024)
Hiroki Jinda, Hiroyuki Watanabe, Kazuma Nakashima, Masahiro Ono
Application of Microfluidic Devices for Automated Two-Step Radiolabeling of Antibodies. Journal of labelled compounds & radiopharmaceuticals 67 (10) (2024)
Ryotaro Onoue, Hiroyuki Watanabe, Masahiro Ono
Development of Novel Bimodal Agents Based on Near-Infrared BODIPY-Conjugated Hoechst Derivatives for Combined Use in Auger Electron and Photodynamic Cancer Therapy. ACS pharmacology & translational science 7 (5) (2024)
Kazuma Nakashima, Hiroyuki Watanabe, Masahiro Ono
Development of Novel Trifunctional Chelating Agents That Enhance Tumor Retention of Radioimmunoconjugates. Journal of medicinal chemistry (2023)
Takahiro Akasaka, Hiroyuki Watanabe, Masahiro Ono
In Vivo Near-Infrared Fluorescence Imaging Selective for Soluble Amyloid β Aggregates Using y-Shaped BODIPY Derivative. Journal of medicinal chemistry (2023)
Shohei Tsuchihashi, Kazuma Nakashima, Yuta Tarumizu, Hiroaki Ichikawa, Hiroki Jinda, Hiroyuki Watanabe, Masahiro Ono
Development of Novel 111 In/ 225 Ac-Labeled Agent Targeting PSMA for Highly Efficient Cancer Radiotheranostics. Journal of medicinal chemistry (2023)
Ryotaro Onoue, Hiroyuki Watanabe, Masahiro Ono
Hoechst-tagged radioiodinated BODIPY derivative for Auger-electron cancer therapy. Chemical communications (Cambridge, England) 59 (7) (2023)
Ryotaro Onoue, Hiroyuki Watanabe, Masahiro Ono
Hoechst-tagged radioiodinated BODIPY derivative for Auger-electron cancer therapy. Chemical communications (Cambridge, England) (2023)
Ryotaro Onoue, Hiroyuki Watanabe, Masahiro Ono
Hoechst-tagged radioiodinated BODIPY derivative for Auger-electron cancer therapy. Chemical communications (Cambridge, England) 59 (7) (2023)
Nobuki Kazuta, Hiroyuki Watanabe, Masahiro Ono
Synthesis and evaluation of 111 In-labeled tetrapeptide-based compounds as single-photon emission computed tomography imaging probes targeting granzyme B. Journal of labelled compounds & radiopharmaceuticals (2023)
Ryotaro Onoue, Hiroyuki Watanabe, Masahiro Ono
Hoechst-tagged radioiodinated BODIPY derivative for Auger-electron cancer therapy. Chemical communications (Cambridge, England) 59 (7) (2023)
Kohei Nakagawa, Hiroyuki Watanabe, Sho Kaide, Masahiro Ono
Structure-Activity Relationships of Styrylquinoline and Styrylquinoxaline Derivatives as α-Synuclein Imaging Probes. ACS medicinal chemistry letters 13 (10) (2022)
Shimpei Iikuni, Ichiro Kamei, Takaki Ohara, Hiroyuki Watanabe, Masahiro Ono
Development of an 111 In-Labeled Glucagon-Like Peptide-1 Receptor-Targeting Exendin-4 Derivative that Exhibits Reduced Renal Uptake. Molecular pharmaceutics 19 (3) (2022)
Sho Kaide, Hiroyuki Watanabe, Shimpei Iikuni, Masato Hasegawa, Masahiro Ono
Synthesis and Evaluation of 18 F-Labeled Chalcone Analogue for Detection of α-Synuclein Aggregates in the Brain Using the Mouse Model. ACS chemical neuroscience 13 (20) (2022)
Kazuma Nakashima, Shimpei Iikuni, Hiroyuki Watanabe, Masahiro Ono
Application of the Chelator-Based Clickable Radiotheranostic Platform to Moderate-Molecular-Weight Ligands. ACS medicinal chemistry letters 13 (10) (2022)
Shimpei Iikuni, Yuta Tarumizu, Shohei Tsuchihashi, Takaki Ohara, Hiroyuki Watanabe, Masahiro Ono
Synthesis and Evaluation of Novel 111 In-Labeled Picolinic Acid-Based Radioligands Containing an Albumin Binder for Development of a Radiotheranostic Platform. Molecular pharmaceutics 19 (8) (2022)
Shimpei Iikuni, Takaki Ohara, Hiroyuki Watanabe, Masahiro Ono
Structure-Activity Relationships and Pharmacokinetics of 111 In-Labeled Glucagon-like Peptide-1 Receptor-Targeting Exendin-4 Derivatives Conjugated with Albumin Binder Moieties. Molecular pharmaceutics 19 (8) (2022)
Hiroyuki Watanabe, Rinka Maekawa, Shimpei Iikuni, Masashi Kakae, Nagisa Matsuo, Hisashi Shirakawa, Shuji Kaneko, Masahiro Ono
Characterization of Radioiodinated Diaryl Oxadiazole Derivatives as SPECT Probes for Detection of Myelin in Multiple Sclerosis. ACS chemical neuroscience 13 (3) (2022)
Hiroyuki Watanabe, Takeaki Kishimoto, Sho Kaide, Yuta Tarumizu, Haruka Tatsumi, Shimpei Iikuni, Masahiro Ono
Characterization and Optimization of Benzimidazopyrimidine and Pyridoimidazopyridine Derivatives as Tau-SPECT Probes. ACS medicinal chemistry letters 12 (5) (2021)
Shimpei Iikuni, Yuta Tarumizu, Kazuma Nakashima, Yusuke Higaki, Hiroaki Ichikawa, Hiroyuki Watanabe, Masahiro Ono
Radiotheranostics Using a Novel 225Ac-Labeled Radioligand with Improved Pharmacokinetics Targeting Prostate-Specific Membrane Antigen. Journal of medicinal chemistry 64 (18) (2021)
Kazuma Nakashima, Shimpei Iikuni, Hiroyuki Watanabe, Masahiro Ono
Development of a novel radiotheranostic platform with a DOTA-based trifunctional chelating agent. Chemical communications (Cambridge, England) 57 (52) (2021)
Shimpei Iikuni, Yuya Okada, Yoichi Shimizu, Hiroyuki Watanabe, Masahiro Ono
Modulation of the Pharmacokinetics of a Radioligand Targeting Carbonic Anhydrase-IX with Albumin-Binding Moieties. Molecular pharmaceutics 18 (3) (2021)
Sho Kaide, Hiroyuki Watanabe, Shimpei Iikuni, Masato Hasegawa, Kyoko Itoh, Masahiro Ono
Chalcone Analogue as New Candidate for Selective Detection of α-Synuclein Pathology. ACS chemical neuroscience 13 (1) (2021)
Sho Kaide, Hiroyuki Watanabe, Yoichi Shimizu, Shimpei Iikuni, Yuji Nakamoto, Masato Hasegawa, Kyoko Itoh, Masahiro Ono
Identification and Evaluation of Bisquinoline Scaffold as a New Candidate for α-Synuclein-PET Imaging. ACS chemical neuroscience 11 (24) (2020)
Hiroyuki Watanabe, Kiyoshiro Kawano, Yoichi Shimizu, Shimpei Iikuni, Yuji Nakamoto, Kaori Togashi, Masahiro Ono
Development of Novel PET Imaging Probes for Detection of Amylin Aggregates in the Pancreas. Molecular pharmaceutics 17 (4) (2020)
Hiroyuki Watanabe, Naoki Matsushita, Yoichi Shimizu, Shimpei Iikuni, Yuji Nakamoto, Kaori Togashi, Masahiro Ono
Synthesis and characterization of a novel 18F-labeled 2,5-diarylnicotinamide derivative targeting orexin 2 receptor. MedChemComm 10 (12) (2019)
Hiroyuki Watanabe, Futa Itagaki, Yoichi Shimizu, Shimpei Iikuni, Masahiro Ono
Synthesis and evaluation of a radioiodinated BODIPY derivative as a thiol-labeling agent. Journal of labelled compounds & radiopharmaceuticals 62 (13) (2019)
Hiroyuki Watanabe, Masahiro Ono, Hideo Saji
Novel PET/SPECT probes for imaging of tau in Alzheimer's disease. TheScientificWorldJournal 2015 (2015)